• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Neurontin (gabapentin) capsules, tablets, and oral solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011

 

Summary View

 

ADVERSE REACTIONS

Postmarketing and Other Experience
  • breast enlargement